NEW YORK (GenomeWeb News) — In an intellectual property lawsuit brought against Roche by Cepheid, a federal court has ordered that a hearing be delayed on whether a PCR patent owned by Roche is invalid and expired until an outcome is achieved in arbitration proceedings between the companies.

The court also has dismissed additional counts by Cepheid against Roche seeking judgment that a second PCR patent owned by Roche is unenforceable, citing a lack of subject matter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.